| Bioactivity | FT206 is an inhibitor of carboxamides as ubiquitin-specific protrase extracted from patent WO 2020033707 A1, example 11-1[1]. | ||||||||||||
| Target | Carboxamides as ubiquitin-specific protrase | ||||||||||||
| Name | FT206 | ||||||||||||
| CAS | 2278274-34-1 | ||||||||||||
| Formula | C25H29N5OS | ||||||||||||
| Molar Mass | 447.60 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. WO2020033707 |
FT206
CAS: 2278274-34-1 F: C25H29N5OS W: 447.60
FT206 is an inhibitor of carboxamides as ubiquitin-specific protrase extracted from patent WO 2020033707 A1, example 11-
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.